Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole
Status:
Terminated
Trial end date:
2018-05-22
Target enrollment:
Participant gender:
Summary
Subjects stable on L-Dopa and oral ropinirole will have their ropinirole replaced with the
Ropinirole Implant(s). The Ropinirole Implant was designed using the ProNeura™ implant
technology where the implant is inserted under the skin. This study will measure how much
ropinirole is released in the blood during 3 months of treatment, and evaluate the side
effects of this new formulation.